Medtronic shows mixed results with strong Cardiovascular growth and weaker Neuroscience/MedSurg. Click here to read an ...

Medtronic posted better-than-expected earnings, lifted its sales forecast, and faces analyst debate on growth prospects and ...

Jellison currently serves as a Senior Advisor for Astor Place Holdings, the Private Equity arm of Select Equities, and ...

Activist investors have targeted major healthcare companies over the past year to push them to improve their performance, ...

The Nasdaq fell as megacaps Nvidia, Microsoft and Meta Platforms lost, after having rallied for much of the year.

“Our decision to become one of Medtronic’s largest investors was driven by our strong conviction that the company is entering ...

The Nasdaq and S&P 500 slid on Tuesday driven by tech stocks, as investors gear up for what Federal Reserve chair Jerome ...

Health-care companies rose as traders rotated into defensive sectors amid a rout in artificial-intelligence companies.

The stock closed nearly 7% higher Tuesday after Japan’s SoftBank (JP:9984) agreed to invest $2 billion in ...

Medtronic(NYSE:MDT) reported first quarter fiscal 2026 results on August 19, 2025, delivering 4.8% year-over-year organic revenue growth and adjusted earnings per share (EPS) of $1.26, which beat the ...

Medtronic appoints two new board directors following talks with activist investor Elliott Investment Management.

"Are we investing enough behind these big growth drivers? We think no. We want to invest more," Medtronic CEO Geoff Martha ...